Regulatory & Legal

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

A new 50MW CO2 heat pump offers a path for factories and cities to ditch boilers. But can industry overcome the high cost and technical hurdles to adopt it?

A new report reveals a massive security blind spot. Unmanaged apps, fueled by AI adoption, are causing data breaches, audit failures, and huge financial losses.

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

Truly Hard Seltzer wants to rename a U.S. town 'Believe' for the summer soccer tournament. Is it a brilliant marketing play or a corporate overreach?

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

After a Nasdaq delisting for compliance failures, Captivision is abandoning its tech past for a risky new venture: a gold rush in Montana.

A major broadband project finishes early, bringing high-speed internet to thousands in underserved areas and future-proofing the state for a digital economy.

Amid global volatility, B2PRIME Group announced record 2025 profits, a 5x surge in volume, and eliminated all debt, setting a new bar for resilience.

TAE Life Sciences' new therapy combines precision radiation with immunotherapy, showing 100% tumor regression in preclinical studies for hard-to-treat cancers.

With new President Vik Shah and SVP Kevin Hoban, North America's top truck body maker eyes innovation and efficiency amid profound industry shifts.

Celebrating a decade of challenging norms, AESARA eyes its next chapter in global health, armed with AI, RWE, and a focus on complex diseases.

A massive data park in Nobles County promises a $30M community fund and huge tax revenues, but faces scrutiny over its environmental footprint.

A new national report quantifies the huge economic and social benefits of affordable housing, even as the system buckles under soaring demand and neglect.

The eyecare tech leader will demo its redesigned EHR at ASCRS 2026, promising streamlined workflows. But can it stand out in a competitive market?

A stunning Q1 2026 revival shows SPACs are not dead. Fueled by veteran sponsors and a focus on AI and defense, a new era for public listings may be dawning.